A Module of Multifactor-Mediated Dysfunction Guides the Molecular Typing of Coronary Heart Disease.

Yuewei Li,Maohuan Lin,Kangjie Wang,YaQing Zhan,Wenli Gu,Guanghao Gao,Yuna Huang,Yangxin Chen,Tucheng Huang,Jingfeng Wang

DOI: https://doi.org/10.1002/mgg3.1415

2020-01-01

Molecular Genetics & Genomic Medicine

Abstract:Background Coronary atherosclerotic heart disease (CHD) is the most common cardiovascular disease and has become a leading cause of death globally. Various molecular typing methods are available for the diagnosis and treatment of tumors. However, molecular typing results are not routinely used for CHD. Methods and Results Aiming to uncover the underlying molecular features of different types of CHD, we screened the differentially expressed genes (DEGs) associated with CHD based on the Gene Expression Omnibus (GEO) data and expanded those with the NCBI-gene and OMIM databases to finally obtain 2021 DEGs. The weighted gene co-expression analysis (WGCNA) was performed on the candidate genes, and six distinctive WGCNA modules were identified, two of which were associated with CHD. Moreover, DEGs were mined as key genes for co-expression based on the module network relationship. Furthermore, the differentially expressed miRNAs in CHD and interactions in the database were mined in the GEO data set to build a multifactor regulatory network of key genes for co-expression. Based on the network, the CHD samples were further classified into five clusters and we defined FTH1, HCAR3, RGS2, S100A9, and TYROBP as the top genes of the five subgroups. Finally, the mRNA levels of FTH1, S100A9, and TYROBP were found to be significantly increased, while the expression of HCAR3 was decreased in the blood of CHD patients. We did not detect measurable levels of RGS2. Conclusion The screened core clusters of genes may be a target for the diagnosis and treatment of CHD as a molecular typing module.